Advertisements



ARCA Biopharma jumps after announcing data from Genetic-AF trial presentation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 11th, 2019

ARCA Biopharma announces GENETIC-AF trial data published

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 1st, 2019

ARCA Biopharma announces data from AFB substudy of GENETIC-AF trial at AHA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2018

ARCA Biopharma presents GENETIC-AF Phase 2B clinical trial results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 29th, 2018

Sun BioPharma Provides Business Update and Reports Operating Results for FY2019

Enrollment completed in fourth cohort of Phase 1a/1b trial of SBP-101 in pancreatic cancer; expansion cohort initiated Interim Phase 1 data presented a.....»»

Category: earningsSource: benzingaMar 24th, 2020

Acer Therapeutics jumps 5% after urea cycle disorders trial data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 24th, 2020

Tonix Pharmaceuticals jumps after announcing TNX-801 presentation at ASM

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 23rd, 2020

Are Investors Overreacting to This Achromatopsia Study?

Applied Genetic Technologies' shares were crushed early on Thursday after the firm reported interim data from its midstage trial in patients with achromatopsia......»»

Category: blogSource: 247wallstJan 23rd, 2020

Applied Genetic Technologies" stock rockets on early-stage eye therapy data

Shares of Applied Genetic Technologies Corp. soared 60% on heavy volume in premarket trading on Thursday after the biotechnology company reported positive results from a Phase 1/2 trial for its investigational gene therapy for retinitis pigmentosa, a dis.....»»

Category: topSource: marketwatchJan 9th, 2020

How This Eye Study Is Making Waves

Applied Genetic Tech shares jumped by more than 50% on Thursday after the firm announced positive interim data from its midstage trial in X-linked retinitis pigmentosa......»»

Category: blogSource: 247wallstJan 9th, 2020

Applied Genetic reports six-month data from ongoing Phase 1/2 trial in XLRP

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 9th, 2020

Principia Biopharma expects final data for Phase 3 PEGASUS trial 2H21

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 30th, 2019

CytomX expects presentation of final data from Phase 1/2 trial of CX-072 in 2020

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 19th, 2019

Principia Biopharma announces preliminary data of Phase 1/2 trial of PRN1008

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 15th, 2019

Principia Biopharma announces preliminary data of PRN1008 from Phase 2 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 10th, 2019

Mereo BioPharma expects 12-month data from Phase 2b ASTEROID trial in Q4

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 17th, 2019

Adverum Shares Sink After Phase 1 Readout From Wet AMD Gene Therapy Trial

Adverum Biotechnologies Inc (NASDAQ: ADVM) shares were plunging Thursday following the presentation of data from its gene therapy trial at a conference. read more.....»»

Category: blogSource: benzingaSep 12th, 2019

Microbot Medical jumps over 5% after announcing presentation plans for SCS

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 5th, 2019

Novavax announces presentation of data from Phase 3 Prepare trial of ResVax

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 12th, 2019

Boston biotech Rhythm"s stock jumps on success of drug for rare form of obesity

Shares of Boston startup Rhythm Pharmaceuticals jumped 20 percent Wednesday after the company announced its drug for two genetic forms of obesity succeeded in a late-stage trial. In a phase 3 trial, Rhythm’s (Nasdaq: RYTM) drug setmelanotide was .....»»

Category: topSource: bizjournalsAug 7th, 2019

Principia Biopharma expects to announce data from Phase 2 trial in Q4

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 30th, 2019